We have shown that the NSCLC-derived exosome miR-3157-3p can be transferred to vascular endothelial cells to target TIMP2/KLF2, by which to promote the angiogenesis and increase the permeability. This evidence concerns the gene KLF2 and non-small cell lung carcinoma.